Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia

  1. Lookup NU author(s)
  2. Professor Stephen O'Brien
  3. Corinne Hedgley
Author(s)Ali S, Sergeant R, O'Brien SG, Foroni L, Hedgley C, Gerrard G, Milojkovic D, Stringaris K, Khoder A, Alsuliman A, Gilleece M, Gabriel IH, Cooper N, Goldman JM, Apperley JF, Clark RE, Marin D, Rezvani K
Publication type Letter
JournalBlood
Year2012
Volume120
Issue3
Pages697-698
ISSN (print)0006-4971
ISSN (electronic)1528-0020
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
AMER SOC HEMATOLOGY
URLhttp://dx.doi.org/10.1182/blood-2012-04-421016
DOI10.1182/blood-2012-04-421016
Actions    Link to this publication
Share